寒武纪等6家企业将退出科创成长层

Core Viewpoint - The first "delisting" wave of the Sci-Tech Innovation Board's growth tier marks a significant milestone in the capital market's service to technological innovation, indicating the effectiveness of the tiered mechanism from establishment to realization of results [3][10]. Summary by Sections Delisting Companies - A total of 39 companies in the Sci-Tech Innovation Board's growth tier have disclosed their 2025 performance data, with 6 companies successfully turning profitable and set to exit the growth tier [1][4]. - The companies include: - Zhongke Hanwuji (营业收入: 64.97 billion, 归母净利润: 20.59 billion) - Baiji Shenzhou (营业收入: 382.05 billion, 归母净利润: 14.22 billion) - Aobi Zhongguang (营业收入: 9.41 billion, 归母净利润: 1.27 billion) - Jingjin Electric (营业收入: 27.26 billion, 归母净利润: 1.62 billion) - Beixin Life (营业收入: 5.42 billion, 归母净利润: 0.81 billion) - Nuo Cheng Jianhua (预计营业收入: 23.65 billion, 预计归母净利润: 6.33 billion) [2][8]. Industry Impact - The delisting of these 6 companies reflects the successful implementation of the tiered mechanism, showcasing how technological breakthroughs can translate into market returns [5][11]. - The companies span key sectors such as innovative pharmaceuticals, high-end medical devices, semiconductors, and artificial intelligence [5][6]. Financial Performance - Zhongke Hanwuji reported a revenue increase of 453.21% to 64.97 billion, marking its first annual profit since its listing [6]. - Baiji Shenzhou achieved a revenue of 382.05 billion, a 40.4% increase, and turned a profit of 14.22 billion, recovering from a loss of 49.78 billion the previous year [7]. - Other companies also reported significant revenue and profit growth, indicating a trend of recovery and profitability in the growth tier [8]. Regulatory Framework - The growth tier's delisting process is governed by specific criteria, including a requirement for companies to achieve positive net profit and revenue thresholds [5][6]. - The establishment of the growth tier has provided a platform for unprofitable tech companies to access capital markets earlier, facilitating their transition from research and development to commercialization [11][12].